Estevão I F, Peitl Junior P, Bonini-Domingos C R
Departamento de Biologia, Universidade Estadual Paulista Júlio de Mesquita Filho, São José do Rio Preto, SP, Brasil.
Genet Mol Res. 2011 Apr 12;10(2):632-9. doi: 10.4238/vol10-2gmr1016.
There have been few studies on the mutations that cause heterozygous beta-thalassemia and how they affect the iron profile. One hundred and thirty-eight individuals were analyzed, 90 thalasemic β⁰ and 48 thalasemic β(+), identified by classical and molecular methods. Mutations in the hemochromatosis (HFE) gene, detected using PCR-RFLP, were found in 30.4% of these beta-thalassemic patients; heterozygosity for H63D (20.3%) was the most frequent. Ferritin levels and transferrin saturation were similar in beta-thalassemics with and without mutations in the HFE gene. Ferritin concentrations were significantly higher in men and in individuals over 40 years of age. Transferrin saturation also was significantly higher in men, but only in those without HFE gene mutations. There was no significant difference in the iron profile among the β⁰ and β(+) thalassemics, with and without HFE gene mutations. The frequency of ferritin values above 200 ng/mL in women and 300 ng/mL in men was also similar in β⁰ and β(+) thalassemics (P > 0.72). Our conclusion is that ferritin levels are variable in the beta-thalassemia, trait regardless of the type of beta-globin mutation. Furthermore, HFE gene polymorphisms do not change the iron profile in these individuals.
关于导致杂合子β地中海贫血的突变及其对铁代谢指标的影响,相关研究较少。我们对138名个体进行了分析,其中90名β⁰地中海贫血患者和48名β(+)地中海贫血患者,通过经典方法和分子方法进行鉴定。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测到30.4%的β地中海贫血患者存在血色素沉着症(HFE)基因突变;H63D杂合子(20.3%)最为常见。HFE基因有无突变的β地中海贫血患者的铁蛋白水平和转铁蛋白饱和度相似。男性和40岁以上个体的铁蛋白浓度显著更高。男性的转铁蛋白饱和度也显著更高,但仅在无HFE基因突变的男性中如此。有无HFE基因突变的β⁰和β(+)地中海贫血患者之间的铁代谢指标无显著差异。β⁰和β(+)地中海贫血女性中铁蛋白值高于200 ng/mL、男性高于300 ng/mL的频率也相似(P>0.72)。我们的结论是,β地中海贫血特征患者的铁蛋白水平存在差异,与β珠蛋白突变类型无关。此外,HFE基因多态性不会改变这些个体的铁代谢指标。